Home > > Middle East & Africa And Global Blood Screening Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Blood Screening market was valued at $280.3 Million in 2023, and is projected to reach $460.4 Million by 2030 growing at a CAGR of 7.40% from 2024 to 2030. Reagents and Kits segment is expected to be the highest contributor to this market, with $220.2 Million in 2023, and is anticipated to reach $360.0 by 2030, registering a CAGR of 7.32%. Software and Services segment is anticipated to reach $18.2 Million by 2030 with the highest CAGR of 9.23%. Reagents and Kits and Instruments segments collectively expected to account for about 96.5% share of the Middle East & Africa Blood Screening market in 2023, with the former constituting around 78.6% share. Software and Services and Instruments segments are expected to witness significant growth rates at a CAGR of 9.23% and 7.36% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 21.4% in the overall Middle East & Africa Blood Screening market in 2023, and is anticipated to reach 21.8% by 2030. Product & Service Reagents and Kits Instruments Software and Services Technology NAT ELISA Rapid Tests Western Blot Assays NGS End User Blood Banks Hospitals BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China India Australia RoAPAC Middle East & Africa Latin America MEA